Health
Singapore develops potential antibody treatment for yellow fever – BSA bureau
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
Researchers from Antimicrobial Resistance (AMR), an interdisciplinary group at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed TY014, a potential antibody treatment for yellow fever. SMART AMR collaborated with researchers from Massachusetts Institute of Technology (MIT), and local institutions such as the Singapore Ge…
-
General24 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News23 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General16 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News13 hours agoAlternative pathways to university explained